Latest Strategic Shift News

BKI Investment Company Limited reported a 10% increase in net profit after tax to $34.3 million for the half-year ended 31 December 2025, alongside a modest rise in its interim dividend. The company’s portfolio performance reflected mixed sector trends amid a volatile market.

Triangle Energy has secured new offshore and onshore permits in the Philippines while initiating legal action against JV partners in Western Australia, signaling a strategic pivot and operational challenges ahead.

Brightstar Resources has released an updated feasibility study for its Goldfields Project, projecting $1 billion in pre-tax free cash flow and a 74% internal rate of return, setting the stage for a Final Investment Decision in March 2026.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.

Liontown Limited has successfully transitioned to 100% underground mining at Kathleen Valley, delivering a 37% increase in underground production and a 91% jump in quarterly revenue. The company is on track to reduce costs and boost recoveries as it targets a steady-state underground run-rate.

Blaze Minerals has confirmed a new critical mineral discovery of gallium and rubidium at its Ntungamo Project in Uganda, while withdrawing from its Congo base metals venture due to security concerns.

BPH Global Ltd has recorded its second highest monthly seaweed sales since May 2025, driven by a strategic shift towards independent operations in Indonesia. The company’s aggregate sales now exceed A$2.15 million, underpinning its growth ambitions for 2026.

Spacetalk Ltd has completed a major pivot from hardware to a scalable software-as-a-service model, driving a 26% increase in active mobile subscribers and a 9% rise in annual recurring revenue to $12 million.

Skylark Minerals has acquired a significant gold project portfolio in Côte d’Ivoire, including the flagship Zaranou Project with an inferred resource of 364,600 ounces. The company completed a A$10 million capital raise to fund upcoming exploration activities and has bolstered its technical team ahead of a busy 2026 drilling season.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its NorthStar Mapping System, the first MRI-native 3D cardiac mapping platform approved in the US. This approval positions Imricor at the forefront of MRI-guided cardiac procedures in the world’s largest electrophysiology market.

Pinnacle Minerals has advanced its strategic pivot to North American critical minerals exploration, initiating fieldwork across multiple US projects and securing a strong cash position of approximately A$2.8 million.